-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
BriaCell Therapeutics Corp. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q3 2021 to Q3 2023.
- BriaCell Therapeutics Corp. Net Cash Provided by (Used in) Operating Activities for the quarter ending October 31, 2023 was -$7.61M, a 115% decline year-over-year.
- BriaCell Therapeutics Corp. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$23.7M, a 90.2% decline from 2022.
- BriaCell Therapeutics Corp. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$12.5M, a 61.1% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)